$APRE PT 25.50+ Gap Up
Aprea Therapeutics, Inc. (APRE) is currently trading near its all-time low, and fell earlier this year due towards a failed late-stage cancer therapy study. In the near-term we could see a bounce off the 5.71 support line, before a fill towards 9.20. After hitting this fill, we should then expect a period of consolidation, and finally a last fill towards 25.50+ with expected good news in a 3-4 month time frame.
Note: this is not an investment idea, just my opinion.
Note: this is not an investment idea, just my opinion.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.